Search research articles
Contact Us
Filters
Showing results (311-320 of 332) with videos related to
Page
of 34
Sort By:
Ophthalmology and Therapy
|
November 30, 2022
Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation
Valerio Carelli, Nancy J Newman, Patrick Yu-Wai-Man, et al.
Cell Reports. Medicine
|
March 1, 2024
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial
Patrick Yu-Wai-Man, Valerio Carelli, Nancy J Newman, et al.
American Journal of Human Genetics
|
November 24, 2015
Recessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic Neuropathies
Claire Angebault, Pierre-Olivier Guichet, Yasmina Talmat-Amar, et al.
Brain Communications
|
May 31, 2021
Dominant <i>ACO2</i> mutations are a frequent cause of isolated optic atrophy
Majida Charif, Naïg Gueguen, Marc Ferré, et al.
Brain : a Journal of Neurology
|
December 26, 2007
OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes
Patrizia Amati-Bonneau, Maria Lucia Valentino, Pascal Reynier, et al.
Neurology
|
June 2, 2023
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
Amel Karaa, Enrico Bertini, Valerio Carelli, et al.
Brain : a Journal of Neurology
|
December 27, 2013
Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy
Carla Giordano, Luisa Iommarini, Luca Giordano, et al.
Orphanet Journal of Rare Diseases
|
November 22, 2024
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial
Amel Karaa, Enrico Bertini, Valerio Carelli, et al.
Journal of Inherited Metabolic Disease
|
September 8, 2020
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network
Michio Hirano, Valerio Carelli, Roberto De Giorgio, et al.
Journal of Clinical Medicine
|
June 2, 2021
Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases
Chiara Ticci, Daniele Orsucci, Anna Ardissone, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 332) with videos related to
Sort By:
Page
of 34
Ophthalmology and Therapy
|
November 30, 2022
Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation
Valerio Carelli, Nancy J Newman, Patrick Yu-Wai-Man, et al.
Cell Reports. Medicine
|
March 1, 2024
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial
Patrick Yu-Wai-Man, Valerio Carelli, Nancy J Newman, et al.
American Journal of Human Genetics
|
November 24, 2015
Recessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic Neuropathies
Claire Angebault, Pierre-Olivier Guichet, Yasmina Talmat-Amar, et al.
Brain Communications
|
May 31, 2021
Dominant <i>ACO2</i> mutations are a frequent cause of isolated optic atrophy
Majida Charif, Naïg Gueguen, Marc Ferré, et al.
Brain : a Journal of Neurology
|
December 26, 2007
OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes
Patrizia Amati-Bonneau, Maria Lucia Valentino, Pascal Reynier, et al.
Neurology
|
June 2, 2023
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
Amel Karaa, Enrico Bertini, Valerio Carelli, et al.
Brain : a Journal of Neurology
|
December 27, 2013
Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy
Carla Giordano, Luisa Iommarini, Luca Giordano, et al.
Orphanet Journal of Rare Diseases
|
November 22, 2024
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial
Amel Karaa, Enrico Bertini, Valerio Carelli, et al.
Journal of Inherited Metabolic Disease
|
September 8, 2020
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network
Michio Hirano, Valerio Carelli, Roberto De Giorgio, et al.
Journal of Clinical Medicine
|
June 2, 2021
Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases
Chiara Ticci, Daniele Orsucci, Anna Ardissone, et al.
Page
of 34